According to Edward Dowd on Twitter, there is a push for a full ban on mRNA technology, which he describes as a 'fantastic beginning' if implemented (source: @DowdEdward, May 15, 2025). For traders, a regulatory move towards banning mRNA could trigger significant volatility in biotech stocks such as Moderna and Pfizer. Historically, heightened regulatory risk in the healthcare sector has prompted capital outflows into alternative assets like Bitcoin and Ethereum, as investors seek safe havens (source: Bloomberg, 2023). This development may lead to increased short-term trading opportunities across both traditional equities and the cryptocurrency market, especially for those watching for sector rotation and risk-off sentiment.